Sectors
-
The Hidden Investing Risk No One Talks About: Cognitive Decline
Investors spend a lot of time debating valuations, interest rates, and where the next recession might come from. Very little time is spent on something that is arguably just as important over the long run: whether we remain capable of making good financial decisions as we age. That is not a comfortable topic. It also
-
Chinese EV Invasion Sparks Canadian Jobs and Price Debate
Canada’s agreement with China on electric vehicles has stirred debate. Some automakers worry it could harm local jobs and disrupt Canada’s EV supply chain. But dealership owners think the move could be good for buyers. More competition could make EVs cheaper and push technology forward. Nazar Navolskyy, co-owner of Favorit Motors in Toronto, said that
-
Ford CEO Highlights Regional Production as New Auto Norm
Jim Farley, Ford’s CEO, said on January 16, 2026 that the auto industry is moving away from globalization. He cited tariffs, political tensions, and protectionist policies. Basically, Ford is saying build closer to your key markets or pay the cost. It makes sense if you think about recent disruptions. The pandemic, chip shortages, and trade
-
Breakthrough: Atossa’s (Z)-Endoxifen Gains FDA Orphan Status for DMD
Atossa Therapeutics (Nasdaq: ATOS) said the FDA granted Orphan Drug Designation for its drug (Z)-endoxifen in Duchenne muscular dystrophy. This follows a prior Rare Pediatric Disease designation. It’s a positive regulatory step. But it does not guarantee approval and it does not make trials any faster. CEO Steven Quay called it an important milestone. He
-
Canadian Natural Resources Projects 3–5% Production Growth in 2026
Canadian Natural Resources (TSX: CNQ, NYSE: CNQ) released its 2026 operating plan, and it’s a story of steady growth rather than headline-grabbing moves. The company expects to produce between 1,590 and 1,650 MBOE per day, which is about 3% higher than 2025 if they hit the midpoint. Liquids make up roughly three-quarters of that, with
-
One Dose, Months of Relief: Eupraxia’s EoE Breakthrough
Eupraxia Pharmaceuticals (NASDAQ:EPRX) (TSX:EPRX) put out an update on its RESOLVE study this week, and the results look encouraging, at least at this stage. The company shared new tissue and symptom data from patients treated with EP-104GI for eosinophilic esophagitis, a condition that remains difficult to treat long term. What stands out most is how
-
MDA Space Lands SHIELD Contract, Expands Defense Opportunities
MDA Space (TSX: MDA) announced it received an IDIQ contract from the U.S. Missile Defense Agency for the SHIELD program. That stands for Scalable Homeland Innovative Enterprise Layered Defense. The program covers work across land, sea, air, cyber, and space. It is a broad initiative with lots of moving parts. Why It MattersCEO Mike Greenley
-
Discovery Silver Ramps Production, Expands Precious Metals Growth
Discovery Silver (TSX: DSV, OTCQX: DSVSF) had a busy year, and Q4 really highlighted how far the company has come. After completing the acquisition of Newmont’s Porcupine operations in April, the company produced 66,718 ounces of gold in the quarter, bringing the total from the acquisition to 180,424 ounces. If you include production before the
-
Bitcoin Isn’t Digital Gold Right Now – Tariffs Show Macro Risk
Last weekend, Bitcoin took a big hit. Prices fell sharply after President Trump announced new tariffs on eight European countries. The move was framed as leverage in ongoing negotiations over Greenland, and it immediately spooked the crypto market. Traders dumped roughly $860 million in long Bitcoin positions in just 24 hours, according to Cointelegraph data.
-
Chinese Biotech Growth Forces U.S. Companies to Innovate Faster
David Li, founder of Meliora Therapeutics, quickly learned that the U.S. biotech space isn’t isolated anymore. While looking at drug targets for his new company, he noticed that a lot of the same targets were already being pursued by Chinese firms. Curious, he went to Shanghai and Suzhou. What he saw surprised him. “They’re all
